JACS
NYSE · N/A
Jackson Acquisition Co-Cl A
$10.59
+0.06 (+0.57%)
Open$10.59
Previous Close$10.53
Day High$10.59
Day Low$10.59
52W High$10.59
52W Low$10.05
Volume—
Avg Volume25.0K
Market Cap253.78M
P/E Ratio34.66
EPS$0.28
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.70M | 9.17M | 10.79M |
| Net Income | 1.60M | 1.49M | 1.93M |
| Profit Margin | 16.5% | 16.3% | 17.9% |
| EBITDA | 3.23M | 2.99M | 3.58M |
| Free Cash Flow | 1.53M | 1.89M | 1.86M |
| Rev Growth | +20.0% | +20.7% | -1.4% |
| Debt/Equity | 0.53 | 0.48 | 0.63 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $8.23 | +8.43% | — | 4.06B |
| PICS | Pics Nv | $11.15 | +6.65% | — | 2.04B |
| DMII | Drugs Made In America Acquis | $9.99 | +0.20% | — | 656.41M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.18B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.56 | +0.05% | 63.3 | 608.01M |
| CEPF | Cantor Equity Partners-Cl A | $10.19 | -0.10% | 356.1 | 583.50M |